↓ Skip to main content

Cochrane Database of Systematic Reviews

Chemotherapy for second-stage Human African trypanosomiasis

Overview of attention for article published in Cochrane database of systematic reviews, June 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

blogs
1 blog
policy
1 policy source
twitter
2 tweeters
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
163 Mendeley
Title
Chemotherapy for second-stage Human African trypanosomiasis
Published in
Cochrane database of systematic reviews, June 2013
DOI 10.1002/14651858.cd006201.pub3
Pubmed ID
Authors

Vittoria Lutje, Jorge Seixas, Adrian Kennedy

Abstract

Human African trypanosomiasis, or sleeping sickness, is a painful and protracted disease affecting people in the poorest parts of Africa and is fatal without treatment. Few drugs are currently available for second-stage sleeping sickness, with considerable adverse events and variable efficacy.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 163 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Argentina 1 <1%
Australia 1 <1%
Unknown 161 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 38 23%
Student > Ph. D. Student 18 11%
Student > Bachelor 17 10%
Researcher 13 8%
Other 9 6%
Other 24 15%
Unknown 44 27%
Readers by discipline Count As %
Medicine and Dentistry 45 28%
Nursing and Health Professions 20 12%
Biochemistry, Genetics and Molecular Biology 13 8%
Agricultural and Biological Sciences 10 6%
Immunology and Microbiology 4 2%
Other 21 13%
Unknown 50 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 September 2022.
All research outputs
#2,018,672
of 22,365,276 outputs
Outputs from Cochrane database of systematic reviews
#4,408
of 12,237 outputs
Outputs of similar age
#16,760
of 174,983 outputs
Outputs of similar age from Cochrane database of systematic reviews
#33
of 139 outputs
Altmetric has tracked 22,365,276 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,237 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.1. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 174,983 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 139 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.